Increased Heart Rate: Some patients may experience a rapid, pounding, or irregular heartbeat
WEGOVY is not recommended in patients with severe gastroparesis. The label does not mention that Wegovy could cause gastroparesis, a claim in many Wegovy lawsuits
Research also suggests that the effects of cardiometabolic health can be affected following discontinuation of semaglutide use, which can increase risk factors for obesity related diseases such as diabetes and hypertension
In the case of Wegovy, additional adverse events reported after it was released to market include: Gastrointestinal disorders, including acute pancreatitis, necrotizing pancreatitis (when part of the pancreas dies) that sometimes results in death, and ileus when muscles in the intestine stop working and food and waste cant pass through the body normally
A comprehensive evaluation should precede any medication start
Drink plenty of water, especially if you experience vomiting or diarrhea
